Clinical Trial Update: Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 [Phase 1]

View source ↗

Summary

Phase 1 update reporting safety and tolerability of PEP005 topical gel applied to up to 100 cm2 in Actinic Keratosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 Topical Gel (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED